AstraZeneca PLC (LON:AZN)
London flag London · Delayed Price · Currency is GBP · Price in GBX
12,006
-140 (-1.15%)
Sep 4, 2026, 5:15 PM GMT

AstraZeneca Stock Forecast

Stock Price Forecast

According to 24 analysts polled by S&P Global, AstraZeneca stock has a consensus rating of "Buy" and an average price target of 15,696p. The average 1-year stock price forecast is 30.73% higher than the current stock price, while the lowest is 11,215p (-6.59%) and the highest is 20,016p (+66.71%).

Price Target: 15,696p (+30.73%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price11,215p15,696p16,203p20,016p
Change-6.59%+30.73%+34.96%+66.71%

Analyst Ratings

The average analyst rating for AstraZeneca stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy151515141414
Buy444455
Hold333433
Sell000000
Strong Sell112222
Total232324242424

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Deutsche Bank
Deutsche Bank
Sell
Maintains
11,500p
SellMaintains11,500p-4.21%Sep 2, 2026
J.P. Morgan
J.P. Morgan
Buy
Maintains
16,000p
BuyMaintains16,000p+33.27%Sep 1, 2026
TD Cowen
TD Cowen
Buy
Maintains
17,775p
BuyMaintains17,775p+48.05%Sep 1, 2026
Jefferies
Jefferies
Buy
Maintains
17,500p
BuyMaintains17,500p+45.76%Aug 28, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Initiates
14,664p
BuyInitiates14,664p+22.14%Aug 24, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
63.24B
from 58.74B
Increased by 7.66%
Revenue Next Year
66.82B
from 63.24B
Increased by 5.66%
EPS This Year
10.26
from 9.16
Increased by 11.97%
EPS Next Year
11.42
from 10.26
Increased by 11.33%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
37.42B44.35B45.81B54.07B58.74B63.24B
Revenue Growth
40.58%18.53%3.29%18.04%8.63%7.66%
Gross Profit
25.41B35.71B37.77B44.44B47.99B52.20B
Gross Margin
67.92%80.52%82.44%82.18%81.71%82.54%
Operating Income
2.90B8.81B9.70B12.93B14.29B21.08B
Net Income
112.00M3.29B5.96B7.04B10.23B12.02B
EPS
----9.1610.26
EPS Growth
----11.57%11.97%
Forward PE
18.6118.6517.0814.3618.3415.83
Dividend / Share
2.872.902.903.103.203.34
Dividend Growth
2.50%1.05%-6.90%3.23%4.36%
Free Cash Flow
-1.85B12.49B9.04B8.46B7.87B9.42B
No. Analysts
-----25
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High64.4B
Avg63.2B
Low62.4B

Revenue Growth

Revenue Growth202620272028
High
9.6%
Avg
7.7%
Low
6.2%

EPS Forecast

EPS202620272028
High10.58
Avg10.26
Low9.99

EPS Growth

EPS Growth202620272028
High
15.5%
Avg
12.0%
Low
9.1%